New treatments for cancer are being developed at a very rapid pace. In order for the treatments to become a standard of care, they need to be tested for safety and effectiveness. The Cancer Center has the ability to offer these treatments through the clinical trials program. Good Samaritan Hospital is affiliated with the Southwest Oncology Group (SWOG) through the University of Kansas Medical Center and the Radiation Therapy Group of The University of California San Francisco. The Cancer Center is also a member of the Cancer Trials of Support Unit (CTSU), sponsored by the National Cancer Institute. Approximately 50 trials are open through the Cancer Center on an ongoing basis.
Catholic Health Initiatives (CHI) has been named by the National Cancer Institute (NCI) as one of 21 sites nationwide to participate in the NCI Community Cancer Centers Program (NCCCP), that brings state-of-the-art cancer care to community hospitals across the nation. The overarching goal of the NCCCP program is to improve access to optimal cancer care and reduce the risk of cancer mortality through an aggressive program of community outreach, bringing multidisciplinary specialty care and clinical research to more patients, and attracting additional patients to enroll early stage clinical trials so promising medications can be tested for safety and effectiveness without delay.
For your convenience, Catholic Health Initiatives now offers an up-to-date online database of cancer clinical trials available at Good Samaritan Cancer Center, Saint Elizabeth Cancer Institute, Saint Francis Cancer Treatment Center and Nebraska Cancer Research Center.